Administration of Candesartan (0.1, 0.5 or 1.0 mg / kg
per day, s.c.) dose dependently inhibited AT binding in
1

the subfornical organ (SFO), paraventricular nucleus of the
hypothalamus (PVN), nucleus of the solitary tract (NTS)
and area postrema (AP) (Fig. 1a,b).
Conversely, Candesartan did not modify the levels of
